In the last trading session, 1.06 million shares of the Relay Therapeutics Inc (NASDAQ:RLAY) were traded, and its beta was 1.72. Most recently the company’s share price was $5.95, and it changed around -$0.01 or -0.17% from the last close, which brings the market valuation of the company to $780.52M. RLAY currently trades at a discount to its 52-week high of $13.32, offering almost -123.87% off that amount. The share price’s 52-week low was $5.92, which indicates that the current value has risen by an impressive 0.5% since then. We note from Relay Therapeutics Inc’s average daily trading volume that its 3-month average coming to 1.21 million.

Relay Therapeutics Inc (NASDAQ:RLAY) trade information

Instantly RLAY has showed a red trend with a performance of -0.17% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -45.96% year-to-date, but still down -12.88% over the last five days. On the other hand, Relay Therapeutics Inc (NASDAQ:RLAY) is -25.72% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $22.83, which translates to bulls needing to increase their stock price by 73.94% from its current value. Analyst projections state that RLAY is forecast to be at a low of $12.5 and a high of $33.

Relay Therapeutics Inc (RLAY) estimates and forecasts

Relay Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -12.37 percent over the past six months and at a -1.79% annual growth rate that is well below the industry average of 10.20%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -38.74%.

RLAY Dividends

Relay Therapeutics Inc’s next quarterly earnings report is expected to be released in May.